
Neautus Looks Outward To Boost Its Traditional Medicine Story
The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China's domestic A-share market Key Takeaways: Neautus has applied to list in Hong Kong, reporting its revenue rose about 9% in 2024, …